Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Small business/Y2K

This article was originally published in The Tan Sheet

Executive Summary

Small Business Administration designates Mark Spellman, Office of General Counsel, as contact person for small businesses that fail to comply with federal rules or regulations due to Year 2000 computer bug problems. Spellman's designation, published in the Sept. 17 Federal Register, comes pursuant to HR 775, signed into law July 20, which generally provides relief from first-time violation penalties for businesses of 50 employees or less due to Y2K failure (1"The Tan Sheet" July 12, p. 15)

You may also be interested in...



Civil Money Penalty Under Y2K Law Could Affect Small OTC/Supplement Firms

Small OTC drug and dietary supplement companies potentially could face civil money penalties for failing to comply with year 2000 liability legislation (HR 775) awaiting President Clinton's signature.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090342

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel